Q5H (p.Gln5His) variant of TP53 (Cellular tumor antigen p53)
Q5H (p.Gln5His) in TP53 (Cellular tumor antigen p53) is a missense change. Clinical records from EBI and UniProt describe it as likely benign in the context of in a sporadic cancer. The available variant effect predictions contribute to a CATVariant prioritization score of 0.27 / 1. The record also includes experimental measurements and structural context.
Q5H (p.Gln5His) variant details
- p.Gln5His
- cosmic curated COSV53772
- Ensembl rs2151047977
- cosmic curated COSV10605
- UniProt VAR 044543
- Likely benign
- in a sporadic cancer
- Missense
- Variant Prioritization Score for Impact Estimate 0.268
- ESM-1b 0.00
- AlphaMissense 0.10
- EBI: Likely benign (in a sporadic cancer)
- UniProt: Likely benign (in a sporadic cancer)
- Structural context available
- p53 variant effect measured by cell growth: score -3.39